Administration of Recombinant Tissue Plasminogen Activator for Sulcal Artery Syndrome

The use of rtPA can result in clinical improvement in symptoms from spinal cord infarction. Spinal cord infarction is a rare type of ischemic stroke and often an elusive diagnosis. The study of recombinant tissue plasminogen activator (rtPA) in spinal cord infarction has been limited due to the rarity of this condition. Here, we present the case of an adult man with spinal cord infarction in a sulcal artery distribution who clinically improved following rtPA administration.

Source: Neurology Clinical Practice - December 13, 2021 Category: Neurology Authors: Lawson, E. C., Hu, R., Silver, M., Greene, J. G. Tags: All Cerebrovascular disease/Stroke, All Spinal Cord, Spinal cord infarction, Infarction Case Source Type: research